LU-31130

LU-31130 Uses, Dosage, Side Effects, Food Interaction and all others data.

LU-31130 is a rapid acting therapy developed by H. Lundbeck A/S to treat Psychosis, Schizophrenia and Schizoaffective Disorders. It acts at the Dopamine D4 receptors in the cortex and has low affinity for D2 receptors, adrenoceptors, muscarinic and histaminergic receptors.It provides anti-psychotic characteristic and a low incidence of extrapyramidal and cardiovascular side effects.

Table Of contents

• LU-31130
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	LU-31130
Generic	LU-31130
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in psychosis and schizophrenia and schizoaffective disorders.

Innovators Monograph

You find simplified version here LU-31130